MHC binding peptides as therapeutic agents.
Metzler
B
B
Department of Pathology, Cambridge University, Addenbrooke's Hospital, U.K.
Fairchild
P J
PJ
Wraith
D C
DC
D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D001665:Binding Sites; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D008285:Major Histocompatibility Complex; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use
D010455:Peptides